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A B S T R A C T
Although neurons attract the most attention in neurobiology, our current knowledge of neural circuit can
only partially explain the neurological and psychiatric conditions of the brain. Thus, it is also important to
consider the inﬂuence of brain interstitial system (ISS), which refers to the space among neural cells and
capillaries. The ISS is the major compartment of the brain microenvironment that provides the immediate
accommodation space for neural cells, and it occupies 15% to 20% of the total brain volume. The brain ISS is a
dynamic and complex space connecting the vascular system and neural networks and it plays crucial roles
in substance transport and signal transmission among neurons. Investigation of the brain ISS can provide
new perspectives for understanding brain architecture and function and for exploring new strategies to
treat brain disorders. This review discussed the anatomy of the brain ISS under both physiological and
pathological conditions, biophysical modeling of the brain ISS and in vivo measurement and imaging
techniques, including recent ﬁndings on brain ISS divisions. Moreover, the implications of ISS knowledge
for basic neuroscience and clinical applications are addressed.
 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).
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amyloid precursor protein; AsF6, hexaﬂuoroarsenate; AQP4, aquaporin4; BBB, blood–brain barrier; BME, brain microenvironment; CCD, charge coupled device; CDPC,
cytidinediphosphate choline; CED, convection enhanced delivery; CNS, central nervous system; CSF, cerebrospinal ﬂuid; CSPGs, chondroitinsulfate proteoglycans; DA,
dopamine; DWI, diffusion weighted imaging; ECM, extracellular matrix; ECS, extracellular space; EVs, extracellular vesicles; GAGs, glycosaminoglycans; GBM, glioblastoma
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In the past century, brain research has been focused on neurons,
their connections, and techniques to record the signals from
individual neurons or neural circuits at high spatial and temporal
resolutions (Scalabrino, 2009; Morgan and Lichtman, 2013;
Hopkins et al., 2014). Despite great advances in neurobiology,
the overall understanding of most neurological and psychiatric
conditions remains limited, and the clinical drug treatment of
brain disorders faces a dilemma of low efﬁciency (Fisher et al.,
2009; Rogawski, 2009; Lam et al., 2011). Brain tissues are
composed of three compartments: neural cells (e.g., neurons
and glial cells), vascular system, and the interstitial system (ISS)
(Fumagalli et al., 2014) (see Fig. 1). Although neural cells have long
been considered the most important functional element of the
brain, they occupy only 70% to 80% of the total brain volume
(Fenstermacher and Kaye, 1988; Sykova and Nicholson, 2008). The
vascular system and ISS together form the brain microenviron-
ment (BME), which constitutes the remaining volume of the brain
and provides the living environment for neural cells. The ISS
occupies 15% to 20% of the total brain volume and was traditionallyFig. 1. Brain tissue compartments and their spatial relationship. Cyan cells
represent neurons, and purple cells represent astrocytes. In the zoom-in subplot,
the extracellular matrix (ECM) is shown as a net-like cover attached to the surface of
neural cells, and its ﬂoating chains of glycoproteins are invisible in ISF. This is a
schematic ﬁgure for identiﬁcation purpose and is not be scale.
Please cite this article in press as: Lei, Y., et al., The brain interstitial sys
Prog. Neurobiol. (2016), http://dx.doi.org/10.1016/j.pneurobio.2015.regarded as a gap ﬁller that functioned in cell maintenance and
adherence. However, recent studies have indicated that the brain
ISS plays a number of active roles in brain function, such as
communication among neural cells, information processing and
integration, and the coordinated response to changes in the
external and internal environments of the brain (Edwards and
Meinertzhagen, 2010; Bechtel and Geschwind, 2013; Deco et al.,
2013; Kastellakis et al., 2014; He et al., 2014). Therefore our
knowledge of neural cells may only partially explain brain
functions and disorders without in-depth consideration of the
inﬂuence of the BME (Morgan and Lichtman, 2013).
The brain ISS is an irregular, tortuous, and narrow space among
neural cells and capillaries; the space between adjacent neural
cells is also known as extracellular space (ECS) (Larsen, 2005). The
width of the ECS between cell bodies ranges from 38 to 64 nm in rat
brains (Thorne and Nicholson, 2006), and it can be as narrow as
20 nm at neuron synapses. The brain ISS occupies approximately
15% to 20% of the total brain volume, and it contains interstitial
ﬂuid (ISF) and extracellular matrix (ECM) (Nicholson et al., 2011).
ECM is produced and secreted by cells, and it surrounds and
attaches to the cell membrane (Michel et al., 2010; Nicholson et al.,
2011; Barros et al., 2011; Coleman et al., 2014). Brain ISF is a water
solvent that contains ions, gaseous molecules, and organic
molecules, and it bathes and surrounds the neural cells (Deitmer
and Rose, 2009; Fuxe et al., 2010). Due to extensive communication
between the cerebrospinal ﬂuid (CSF) and ISF, CSF is also
considered a reservoir for ISF and the ultimate site of removal
of most waste products from the brain ISF (Milhorat, 1975). The
CSF occupies the subarachnoid space and the ventricular system
around or inside the brain parenchyma, and it acts as a mechanical
cushion or buffer for the brain. It has been reported that
approximately 20% of CSF in the human brain originates from
brain ISF (Edsbagge et al., 2004; Perez-Figares et al., 2001).
The vascular system occupies 3% to 5% of the brain volume
(Fenstermacher and Kaye, 1988), and substance exchange between
the plasma and ISF occurs at the capillaries (Ide and Secher, 2000).
The distance between a neuron and the nearest capillary ranges
from 10–20 mm, and this distance guarantees a higher efﬁciency
for diffusion-based substance exchange between capillaries and
neurons (Mabuchi et al., 2005). The capillaries in brain tissue
characterize the structure of the blood–brain barrier (BBB) (Pan
and Kastin, 2007; De et al., 2013). The BBB is a highly selective
permeability barrier formed by capillary endothelial cells,
pericytes and endfeet of astrocytes, where the endothelial cells
are connected by tight junctions with an extremely high electricaltem: Anatomy, modeling, in vivo measurement, and applications.
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Fig. 2. Three compartments of the brain and their substance exchanges. The solid
blue line represents the ‘one-way’ exchange of substances, and the dashed red line
represents interactive exchanges.
Fig. 3. Brain ECM, and an enlarged view of the zoom-in subplot in Fig. 1. The net-like
cover represents hyaluronic acid (HA) secreted by cells, which acts as a trestle for
the ECM net-like structure. The penniform objects that cross the gaps between the
HA chains are glycoproteins (mainly CSPGs in the brain). Tenascin is shown as an
orange triple-circle that links glycoproteins up. The colorful single circles represent
example components of ISF, e.g., water molecules (H2O), extracellular vesicles
(EVs), matrix metallopeptidase (MMP), glucose (Glu), dopamine (DA), and tissue
plasminogen activators (tPAs). This ﬁgure demonstrated that the ECM acts as an
intercellular adhesion and scaffold. This is a schematic ﬁgure for identiﬁcation
purpose and is not be scale.
Y. Lei et al. / Progress in Neurobiology xxx (2016) xxx–xxx 3
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allows the passage of water, small hydrophobic molecules (O2, CO2,
hormones), and lipid soluble molecules by passive or simple
diffusion, as well as the selective transport of molecules such as
glucose and amino acids by facilitated diffusion or active transport
(Brasnjevic et al., 2009; Figley and Stroman, 2011).
In Fig. 2, Three major compartments of brain tissue (i.e., neural
cell, vascular system, and ISS) and their constituents are, and
the substances exchanges between each compartment are
illustrated.
After the above brief introduction to brain architecture and BME
organization, the properties of the brain ISS are presented as
follows. In Section 2, the anatomy of the brain ISS is discussed.
Section 3 illustrates the properties of ISF and a new ﬁnding, i.e.,
divisions of the brain ISS. In Section 4, substance transport and the
biophysical modeling of the ISS are addressed. Section 5 presents in
vivo measurement techniques for the ISS. In Section 6, alternations
of the ISS associated with the neuropathology of several brain
disorders are introduced. Section 7 discusses the practical use of
ISS knowledge, especially promising application in the local
delivery of central nervous system (CNS) therapeutics. Section 8
represents some concluding remarks.
2. The anatomy of the brain ISS
2.1. ISS Geometry and boundaries
The geometry of the brain ISS undergoes alterations throughout
the lifespan during the development, maturation, and aging of the
brain, and these changes are related to neuronal migration, neuron
differentiation, synapse formation, myelination, regressive
processes, and the organization and reorganization of the brain
(Bielas et al., 2004; Faissner et al., 2010; Florio and Huttner, 2014).
Even each neuronal excitation is accompanied with the alteration
in the ISS, which is secondary to the instantaneous cell swelling
during excitation (Le Bihan and Johansen-Berg, 2011).
Brain cells include neurons and various types of glial cells.
Generally, glial cells outnumber neurons, and the ratio varies in
different brain regions (Pelvig et al., 2008; Azevedo et al., 2009a,
2009b). Neurons are connected to several thousands of other
neurons by means of axons and synapses. The diameter of most
neuron bodies ranges from 5–10 mm, and axons can be as long as
1 m. The body width of oligodendrocyte ranges from 1–3 mm, and
their processes extend to wrap around axons and form the myelin
sheath (EI Waly et al., 2014). Astrocytes are approximately 10 mm
in diameter, and they can extend much larger during excitation
(Wolak and Thorne, 2013).Please cite this article in press as: Lei, Y., et al., The brain interstitial sys
Prog. Neurobiol. (2016), http://dx.doi.org/10.1016/j.pneurobio.2015.Tortuosity and volume fraction are two general parameters
depicting the geometry of the brain ISS (Nicholson, 2001). The
volume fraction (a) is deﬁned as the ratio of ISS volume to total
brain volume and ranges from 15% to 20% in normal adult brain
tissue. ISS tortuosity is empirically deﬁned as the ratio of path
length for transport to the straight distance between two points in
the ISS, and it can be estimated by calculating the square root of the
ratio between the measured diffusion coefﬁcient in a free medium
and that measured in the ISS (the most commonly used ‘‘free’’
medium in studies of the brain ISS study is a dilute agarose gel).
The estimated values of these biophysical parameters of the brain
ISS are affected by the selection of measurement techniques, e.g.,
using the radiotracer method, the ISS tortuosity ranges between
1.4 and 1.7 (Sykova and Nicholson, 2008), using real time
iontophoresis tetramethylammonium+ (RTI-TMA+) measurement
the ISS tortuosity mostly varies from 1.5 to 1.8 (Rusakov and
Kullmann, 1998; Nicholson, 2001; Sykova and Nicholson, 2008),
and the tortuosity is greater than 2 by using integrative optical
imaging (IOI) technique (Nicholson, 2001). Using a tracer-based
magnetic resonance imaging (MRI), the ISS tortuosity in rat
caudate nuclei ranges from 1.3 to 1.8 (Han et al., 2014).
The boundary structure of the ISS is made of the cell membrane
and the wall of blood vessels (Nicholson et al., 2011). The cell
membrane (plasma membrane) has aphospholipid bilayer structure
with a thickness of approximately 5 nm at the outermost layer. The
cell membrane separates the cytoplasm from the outside environ-
ment, and it is selectively permeable to speciﬁc ions and organic
molecules with the aid of embedded proteins (Alberts et al., 2007;
Gu and Barry, 2011; Arish et al., 2015; Nicolson, 2015; Bouter et al.,
2015). The cell membrane serves as the attachment surface for ECM
and thus maintains ISS geometry (Malmstadt et al., 2006).
2.2. Extracellular matrix
As noted in Section 1, the ISS is composed of ISF and ECM. Fig. 3
shows the components and structure of the ECM, which provides
structural and biochemical support to the attached cells. The ECM
is a highly hydrated net-like structure produced and secreted bytem: Anatomy, modeling, in vivo measurement, and applications.
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elastin, glycosaminoglycans (GAGs), proteoglycans, and glycopro-
teins (tenascin, reelin, laminin and ﬁbronectin) (Crocker et al.,
2004; Michel et al., 2010; Lau et al., 2013). Compared to other body
tissues, the ECM in brain tissue contains less collagens but more
proteoglycans (Zimmermann and Dours-Zimmermann, 2008;
Rozario and DeSimone, 2009).
ECM can be further classiﬁed into various types, and its
components and structure may vary between locations. Perineur-
onal nets (PNNs) are pericellular structures of ECM at neural cell
bodies, axosomatic synapses, and proximal dendrites (Frischknecht
et al., 2009). PNNs are condensed mesh-like structures consisting of
CSPGs, HA, linking proteins and tenascin-R. The pericapillary matrix
(PCM), also known as the basement membrane and basal lamina, is a
sheet-like layer that is continuous with the pia matter of the brain; it
mainly contains collagen IV, laminins, ﬁbronectin, dystroglycan and
perlecan (Itoh et al., 2011). In addition, the brain ISS contains
diffusely distributed interstitial matrix, which consists of proteo-
glycans, HA, and a small amount of collagens, laminins and
ﬁbronectin. The components of the ECM, their functions, and
related brain disorders are described in Table 1.
HA is strongly negatively charged; thus, it mostly attracts
positive ions and positively charged proteins. HA maintains the
hydration of ECM and connects the cell body and lecticans.
Moreover, HA contributes to the movement and proliferation of
cells through interactions with cell surface receptor (Bandtlow and
Zimmermann, 2000; Dityatev and Schachner, 2003; Anlar and
Gunel-Ozcan, 2012; Hopkins et al., 2014).
Members of the lectican family, e.g., CSPGs and HSPGs, can bind
with receptors and coat on the neuronal surface. Combined with
HA and tenascins, lecticans store various proteins in the ISS, such asTable 1
Major components of ECM of the brain ISS (abbreviations can be found at the end of t
Family Components Distribution R
GAGs CS PNNs, NIM 
HS PCM
HA PNNs, NIM G
c
Proteoglycans CSPGs (also known
as lecticans)




HSPGs Glypicans PNNs, PCM A
Syndecans A
Glycoproteins Tenascins C PNNs G
UTenascins R PNNs, NIM
Reelin PNNs A
Laminins PCM G
Fibronectin PCM, NIM M
U
Collagens Collagen IV PCM, NIM A
Collagen XV
Collagen XVII A
AD: Alzheimer’s disease, CSPGs: chondroitin sulfate proteoglycans, GAGs, glycosaminog
proteoglycans, NIM: neuronal interstitial matrix, PCM: percapillary matrix.
Please cite this article in press as: Lei, Y., et al., The brain interstitial sys
Prog. Neurobiol. (2016), http://dx.doi.org/10.1016/j.pneurobio.2015.chemokines, proteases and axon guidance molecules. Lecticans are
believed to regulate neurogenesis and synaptic plasticity and to
contribute to capillary basement membrane formation (Dityatev
and Schachner, 2003; Kantor et al., 2004; Sugahara and Mikami,
2007; Purushothaman et al., 2012a, 2012b; Dick et al., 2013;
Hopkins et al., 2014). Tenascins are associated with dendrites
growth, synaptic plasticity, cell attachment and migration.
Tenascin-R is a crosslinker for lectican, and tenascin-C is associated
with cell attachment and migration. Reelin is another ECM
glycoprotein. During development, reelin promotes the neuronal
migration and the organization of cell layer. Reelin can modulate
synaptic plasticity and contributes to the dendrites development,
and short-term and long-term potentiation (Ogawa et al., 1995;
Stranahan et al., 2013). Laminins are high-molecular-weight
glycoproteins, that are distinguished by their assembly of three
disulﬁde-linked polypeptide chains. Laminins are involved in
constructing the basal lamina and serve as an integrator by binding
to cell membranes and contributing to cell attachment, differenti-
ation and migration. Although the expression of collagen family is
lower in the brain than in body tissues, this family plays an
important role in axon guidance and synaptogenesis (Fox, 2008;
Hubert et al., 2009). Degradation of collagen XVII, XV and IV
produces three cytokines in the ISS, i.e., endostatin, restin
and arresten, respectively. These cytokines can affect the
physiological functions of neural cells (Ramchandran et al.,
1999; Colorado et al., 2000).
The components of PNNs are dynamically regulated in
responses to emotions such as fear, reward, and stress, as well
as immune activities (Gogolla et al., 2009; Xue et al., 2014), and the
integrity of the PNN is damaged during trauma, epilepsy, tumor
and schizophrenia (Balmer et al., 2009; Bavelier et al., 2010;his table).
elated brain diseases Overview
A family of negatively charged chains with
repeating disaccharide units. The family includes
ﬁve groups: chondroitin sulfate, heparan sulfate,
dermatin sulfate, keratin sulfate and HA. Except
for HA, GAGs are sulfated on the sugar residues
and attached to the core proteins for forming the
proteoglycans.
26 and U373 MG glioma
ells
BM As the most abundant components of brain ECM,
CSPGs have a c-typelectin domain on the C-
terminus and a HA linking site on the N-terminus.
CSPGs include three groups: lecticans,
phosphacan and neuron-glial antigen
2. Generally, lecticans are the symbols of CSPGs
and include brevican, neurocan, aggrecan and
versican. They bind HA and tenansins and form
the highly organized structure of PNNs.
S, ischemic stroke, GBM
BM
S, ischemic stroke, GBM
D, ischemic stroke Abundant groups in proteoglycans family. At least
16 groups have been found and most of them
have transmembrane proteins and attaches the





The glycoproteins are abundantly expressed in
the developing and matured brain. They affect






D, GBM The family consists of a right-handed triple
helical structure composed of three polypeptide
chains with a recurring Gly-X-Y sequence (where
X and Y are usually proline and hydroxyproline
respectively)
D
lycans, GBM: glioblastomamultiforme, HA: hyaluronic acid, HSPGs: heparan sulfate
tem: Anatomy, modeling, in vivo measurement, and applications.
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et al., 2013; Mauney et al., 2013; Ye and Miao, 2013; Vargova and
Sykova, 2014). ECM in the brain ISS may hinder ISF ﬂow or
substance transport (Wolak and Thorne, 2013). Moreover, the
negatively charged components of the ECM, such as HA, may
disturb the movement of charged substances in the ISS (Sykova and
Nicholson, 2008).
3. The Brain interstitial ﬂuid
3.1. The components of brain ISF
The brain ISF bathes and surrounds neural cells, and it provides
the immediate medium for nutrients supply, waste removal and
intercellular communication (Howell and Gottschall, 2012). ISF
include water, ions, gaseous molecules, and organic molecules,
such as proteins, peptides, enzymes, dopamine, extracellular
vesicles (EVs), and the ﬂoating chains of glycoproteins attached
to the ECM. There are few reports of the production or sources of
ISF. Correlation studies of ISF and CSF suggest that ISF may
originate from CSF, cell metabolism and the vascular system
(Abbott, 2004; Magistretti, 2006; Rafalski and Brunet, 2011; Iliff
et al., 2012; Brinker et al., 2014).
Substance exchange between the ISS and the neural cell
compartment exists throughout the entire lifespan of a cell
(Magistretti, 2006). Neuronal activities are accompanied by the
exchange of ions through the cell membrane. Neural cells maintain
inner osmolarity through various ions, proteins and organic
compounds (Kristensson and Olsson, 1973). The relatively higher
osmolarity in neural cells drives water molecules from the brain
ISS into neural cells with the aid of channel proteins, such as AQP4
and Na+/K+-ATPase enzymes in the cell membrane, which are
activated upon neurocyte excitation (Yuan et al., 2005; Tian et al.,
2005).
The peptides and proteins manufactured in the brain ISS differ
in composition due to local biochemical processes, such as the
proteolytic process involved in cell surface remodeling, protein
shedding, and the synthesis of regulatory peptides (Zougman et al.,
2008). Some of the above active molecules can also be found in the
CSF, and the long-distance transport of active substances by ISF-
CSF exchange has been suggested to be essential for the onset and
maintenance of speciﬁc behavioral or motivational states, e.g., fear,
appetite, mood, and circadian rhythms (Hobson and Friston, 2012).
A series of enzymes in brain ISF are responsible for the
degradation and remodeling of ECM proteins, such as matrix
metallopeptidases (MMPs), tPAs, plasminogen activator inhibitors,
hyaluronidase, heparanase, and chondroitinase. These enzymes
are secreted by neurons, oligo dendrocytes, microglia and
endothelial cells (Lo et al., 2002). MMPs are a subfamily of zinc-
dependent proteases, that are mainly synthesized in neurons and
microglial cells. MMPs are relatively prevalent in brain areas
related to learning and memory (Melchor and Strickland, 2005),
and they play a wide variety of roles in the brain that include
development, synaptic plasticity, and repair after brain disorders,
such as Alzheimer’s disease, multiple sclerosis, ischemia/reperfu-
sion and Parkinson’s disease (Conant et al., 1999). tPAs can convert
inactive plasminogen to active plasmin and are correlated the
neuronal plasticity, ECM degradation, microglial activation, as well
as the abnormal accumulation of amyloid plaques (Bonneh-Barkay
and Wiley, 2008).
EVs are released from glial cells and neurons during normal
development, physiologic homeostasis, and response to patho-
genic conditions (Agnati and Fuxe, 2014). The release process is
energy dependent, and involves exocytosis. EVs are spherical
structures that contain water-soluble components and are formed
at the plasma membrane (membrane particles) by direct buddingPlease cite this article in press as: Lei, Y., et al., The brain interstitial sys
Prog. Neurobiol. (2016), http://dx.doi.org/10.1016/j.pneurobio.2015.or shedding into the extracellular space. EVs range from 30 nm to
1 mm in size and include distinct subtypes such as exosomes,
microvesicles and apoptotic bodies. These vesicles may contain
signaling proteins and both coding and regulatory ribonucleic
acids (RNAs), and they can be taken up by target cells, thereby
facilitating cell–cell communications (Rajendran et al., 2014). In
addition to acting as important mediators of intercellular
communication, EVs can regulate a diverse range of biological
processes including nerve regeneration, synaptic function, and
behavior (Samir et al., 2013). EVs also play a sinister role in
neurodegenerative diseases, infectious inﬂammatory diseases, and
tumor-genesis in the brain. Thus, EVs may potentially be used as
biomarkers of CNS diseases (Hochberg et al., 2014).
Gaseous molecules and small hydrophobic, lipid soluble
molecules within blood plasma can passively diffuse across the
endothelium and enter the ISS. Their passive diffusion is driven by
concentration differences between the two compartments. Water,
ions, and small polar and charged molecules cross the endothelium
via channels and transporters (e.g., Na+/K+-ATPase). These
membrane proteins are asymmetrically distributed in the endo-
thelium, which is essential to maintain the isotonicity of the local
cellular microenvironment (Abbott, 2004).
3.2. ISF ﬂow and drainage route
The biophysical and biochemical balance between CSF and ISF is
crucial for the metabolism of brain cells and drugs. The Brain
lymphatic vasculature and the drainage pathway of brain ISF have
long been controversial topics (Abbott, 2004; Louveau et al., 2015).
With progress in neuroscience research, three potential pathways
have been suggested. One pathway occurs at the wall of the ventricle
through ependymal cells, and the other exists at the surface of the
brain and spinal cord via pia-glial membranes (Pollock et al., 1997;
Iliff et al., 2012). These two pathways involve direct exchanges
between ISF and CSF, which are identiﬁed using optical imaging
techniques. The third pathway is the blood vessel wall, where ISF can
ﬂow within the basement membrane directly opposite to blood
ﬂow, and eventually reaching extracranial lymph nodes (Bradbury
et al., 1981; Abbott, 2004; Carare et al., 2008; Lonser et al., 2015). The
most recent studies have revealed lymphatic vessels in the CNS,
where CSF may reach deep cervical lymph nodes (Louveau et al.,
2015). Conventional optical techniques may only provide the
micron-depth images of the brain cortex. With newly developed
in vivo tracer-based MRI techniques, these pathways have been
validated and the corresponding mechanisms partially clariﬁed
(Han et al., 2012; Shi et al.,2015).
Ependymal cells cover the inner ventricle surfaces with tight
junctions. Unlike in the BBB, these tight junctions between
ependymal cells are seldom regarded as a real barrier to substance
transport because they allows the passage of macromolecules,
such as ferritin and inulin (Goldman, 1913; Rall, 1968; Saunders
et al., 2008; Johanson et al., 2011). This ISF-CSF communication at
the inner ventricle surface has been considered to explain the
pathological changes that occur in acute-stage hydrocephalus
(Weller et al., 2009a, 2009b). The sudden increase in ventricle
pressure causes high ependymal permeability and enhances the
ﬂow from CSF to ISF; this further results in interstitial edema of
white matter (Laman and Weller, 2013).
In cases of hydrocephalus, interstitial edema seldom appears in
gray matter of the cerebral cortex, which may be explained by the
more efﬁcient drainage from ISF to CSF by the second pathway. The
second pathway can be demonstrated using in vivo two-photon
imaging with the aid of a ﬂuorescent probe injected into the
subarachnoid CSF. Driven by arterial pulsation, the ﬂuorescent
probe distributed to the brain ISS along the paravascular spaces
surrounding the penetrating arteries. Finally, the probe is clearedtem: Anatomy, modeling, in vivo measurement, and applications.
12.007
Fig. 4. Pathways of ISF drainage to CSF in brain. ISF can exchange with CSF in the
ventricles and subarachnoid spaces, and ISF can also drain to cervical lymph nodes.
Mark A denotes that ISF can drain into ventricles through ependymocytes; mark B
denotes that ISF drains into subarachnoid spaces; and mark C denotes that ISF may
drain directly along the walls of capillaries and arteries to cervical lymph nodes. The
arrows represent the major direction of ﬂuid movement, and thin arrows represent
the minor direction.
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et al., 2012). Similar drainage from ISF in the cortex to CSF in the
subarachnoid space has also been veriﬁed using tracer-based MRI
(Han et al., 2012). With the aid of water-soluble tracer gadolinium
diethylenetriaminepentacetic acid (Gd-DTPA), water molecules in
the brain ISF are speciﬁcally ‘‘lightened’’ on MRI, allowing the
dynamic distribution of brain ISF ﬂow to be traced at the whole
brain scale. It has been found that the traced brain ISF in caudate
nuclei ﬂows and distributes to the ipsilateral cortex with in 2 h, it
then reaches the cortex margin and ﬁnally drains into the
subarachnoid space (Han et al., 2014). MRI using a SPIO tracer,
showed that the substance tranportation from the brain ISF to the
deep cervical lymph nodes can be demonstrated by way of the
olfactory bulb and nasal lymphatics (Muldoon et al., 2005). Fig. 4
illustrated these multiple potential pathways of ISF drainage.
3.3. Divisions of the brain ISS based on ISF ﬂow
Recently, research on the brain ISF ﬂow in the deep brain of
rats indicate the presence of a new division system in the brain.
As described in Section 3.1, the ISF from caudate nuclei ﬂows
toward the ipsilateral cortex and ﬁnally drains into the
subarachnoid space (Pardridge, 2011; Han et al., 2012). Although
thalamus is located near the caudate nucleus, the traced brain ISF
does not ﬂow to it but moves in the opposite direction to the
cortex. Moreover, the traced brain ISF in the thalamus does not
cross the ‘‘boundary’’ between the thalamus and the caudate
nucleus (Han et al., 2014; Shi et al.,2015; Zuo et al., 2015), and
this observation has been preliminarily validated using optical
techniques (Li et al., 2015). This ﬁnding indicates that the ISF in
the brain ISS cannot distribute or ﬂow globally; but is restricted
to certain divisions or territories. In other words, the brain ISS
contains functional divisions based on brain ISF ﬂow. The division
is characterized by the probe’s maximal volume distribution
(Vdmax) and ﬂow speed. Vdmax is deﬁned as the ratio of the
maximal distribution volume of the probe in the brain ISS to the
total brain volume. Because the clearance of the tracer in the rat
brain is consistent with exponential decay, the clearance speed
of the tracer in the ISS is described in terms of half-life (t1/2) (the
time required for the tracer amount to decrease by half). The ratio
of Vdmax to brain volume for caudate nucleus (10.27  0.19%) isPlease cite this article in press as: Lei, Y., et al., The brain interstitial sys
Prog. Neurobiol. (2016), http://dx.doi.org/10.1016/j.pneurobio.2015.greater than that for the thalamus (2.30  0.62%). The t1/2 of the
thalamus (1.40  0.12 h) is signiﬁcantly shorter than that in the
caudate nucleus (0.81  0.03 h) (Zuo et al., 2015).
Although more studies are still necessary to reveal the
locations and properties of all the brain divisions, the biophysical
properties of brain ISF ﬂow in the two divisions as discussed
above have been employed to improve interstitial drug delivery
efﬁciency (Xu et al., 2011a; Han et al., 2012). This advance will
also provide valuable biophysical parameters for establishing 3-D
brain tissue culture models. Moreover, the traditional concept of
CNS drug distribution in brain tissue may be improved with the
new concept of ISS-based functional divisions. Speciﬁcally, the
use or development of CNS drugs must consider these functional
divisions for precise and efﬁcient drug distribution at ISS lesions
instead of the whole brain. Understanding the regulation of brain
ISF ﬂow in each division of the ISS is a more challenging task (Shi
et al., 2015). Clarifying substance transport in the brain ISS is
necessary to establish a suitable biophysical model to form the
basis for further quantitative analyses and mechanism studies of
this complicated brain ISS.
4. Modeling of substance transport in the brain ISS
4.1. The mechanisms of substance transport in the ISS
Substance transport in the brain ISS is a complicated process,
and it is determined by both the biophysical properties of the brain
ISS and the chemical properties of the substances in the ISS. Recent
works have veriﬁed that both bulk ﬂow and diffusion are
mechanisms of substance transport in the ISS, i.e., substance
transport in the ISS can be driven by both concentration
gradient and pressure gradient (Cserr et al., 1981; Cserr and
Patlak, 1992; Abbott, 2004; Han et al., 2012). The brain ISF and
interior substances have a broad spectrum of physical and
chemical differences, such as molecular size, water or lipid
solubility, charge, concentration of substances, pH, temperature,
and viscosity. The geometry of the brain ISS determines the
trajectory of substance transport and brain ISF ﬂow.
The movement of ISF molecules in the narrow and torturous
ISS mostly takes the form of hindered diffusion, where the
diffusion rate is much lower than that in free space (Dityatev
and Schachner, 2003; Tao and Nicholson, 2004; Sen and Basser,
2005). As illustrated in Section 5, the measurement of substance
transport in the brain ISS depends on the molecular probe
injected into the ISS. As expected, the physical and chemical
properties of these probes also affect the measurement results,
and various measurement results of diffusion rates have been
reported in previous works. Using a tetramethylammonium+
(TMA+) probe (molecular weight of 74), the measured tortuosity
of the brain ISS mostly ranges from 1.3 to 1.8 (Rusakov and
Kullmann, 1998; Sykova and Nicholson, 2008; Xie et al., 2013).
This result indicates that the diffusion coefﬁcient of TMA+ in the
brain ISS is approximately 30% to 60% of that measured in free
medium. The functional MRI technique of diffusion weighted
imaging (DWI), provides the apparent diffusion coefﬁcient
(ADC) of water molecules in each image pixel, which indicates
the average diffusivity of water molecules. DWI reveals that the
typical diffusion rate of water molecules in the brain is found to
be 20% to 25% of that in free medium (Baumann et al., 2012;
Klimas et al., 2013). Water molecules have a diameter of 2.7 A˚
(Zhang and Xu, 1995), which is much smaller than organic
molecules. These macromolecules are almost equally impacted
by water molecules, and their diffusion rate is much slower than
that of water in both the ISS and free medium. In agarose, the
diffusion rate of dextran molecules (molecular weight of 3000)tem: Anatomy, modeling, in vivo measurement, and applications.
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(Nicholson, 2001).
Bulk ﬂow, another important mechanism of substance trans-
port in ISS (Cserr et al., 1981; Cserr and Patlak, 1992; Abbott, 2004;
Han et al., 2012) is suggested to be partially caused by arterial
pulsation (Iliff et al., 2013), where arterial pulsation refers to
periodic dilation of arterial walls driven by the pulsatile blood ﬂow.
As reported in early works (Rosenberg et al., 1980; Ichimura et al.,
1991; Yamada et al., 1991), the velocity of bulk ﬂow of ISF ranges
within 5–15 mm per minute in white matter, and it is unrelated to
the diffusion rate. The bulk convection of macromolecules is
signiﬁcantly constrained by the narrow diameter of the ISS, and the
movement of macromolecules of with a molecular weight of
50,000 could be less than 1 mm per day (Raghavan et al., 2006).
ISS geometry determines the boundary conditions of the ﬂuid
ﬁeld inside ISS, and thus has a signiﬁcant inﬂuence on the
substance transport in the ISS (Yuan et al., 2005). Moreover, the
surface properties of the ECM are other factors that affect
substance transport in the ISS. For example, the HA in brain
ECM is highly negatively charged, which has a clear inﬂuence on
the transport of ions, charged molecules and nanoscale particles
in the ISS, such as cationic liposomes (MacKay et al., 2005).
Shielding the positive charge of cationic liposomes to confer either
neutrality or anionic charge can signiﬁcantly improve the
distribution (Saito et al., 2006; Kikuchi et al., 2008). Some
proteins in the cell membrane can also actively regulate substance
transport in the brain ISS. Aquaporin 4 (AQP 4) occupies 50% of the
surface area of capillary-facing endfeet of astrocytes along the
blood–brain barrier and brain–CSF interfaces (Haj-Yasein et al.,
2011; Verkman, 2012). The water molecules entering cells
through AQP4 channels cause swelling of astrocytes and decrease
the ISS volume fraction, and this process can further change the
diffusion or bulk ﬂow in the ISS (Papadopoulos and Verkman,
2007; Iliff et al., 2012).
4.2. Biophysical parameters and modeling of the ISS
From the discussions above, it is known that many properties of
the ECM and ISF can inﬂuence substance transport in the ISS (Taber
and Hurley, 2014; Pistillo et al., 2014). An in-depth understandingTable 2
The biophysical parameters of geometry and ECM of ISS.
Category Parameter Unit D













Electric conductivity Siemens/m E
Thermal conductivity W/(mmK) T
Components concentration mmol/ml C
Substances transport
and ISF drainage
Flow velocity mm/s F
s





Clearance rate mmol/(sml) C
Please cite this article in press as: Lei, Y., et al., The brain interstitial sys
Prog. Neurobiol. (2016), http://dx.doi.org/10.1016/j.pneurobio.2015.of the mechanisms and methods of regulating substance transport
in the brain ISS will beneﬁt the investigation of new drugs to treat
brain diseases.
Table 2 presents a comprehensive summary of biophysical
parameters related to the ISS (Nam and Kaviany, 2003). As
discussed in Section 5, only a small number of parameters
can be quantitatively acquired using current measurement
techniques. These parameters characterize the biophysical prop-
erties of the brain ISS, and the extraction and analysis of biological
parameters of the brain ISS are usually conducted with the aid of
probes injected into ISS (Han et al., 2014).
Biophysical modeling of the brain ISS is a fundamental
approach for extensively analyzing of its properties. The results
from current biophysical modeling of the brain ISS are consistent
with the measurement results, and have even successfully
predicted the existence of ‘‘dead space’’ in ISS (Sykova and
Nicholson, 2008). The biophysical modeling of brain ISS mainly
includes two parts: (1) the modeling of ISS boundary condition and
ECM, and (2) the modeling of substance transport in ISS.
The spatial organization and surface properties of the ISS
boundary and ECM determine the boundary condition of substance
transport in the ISS, and multiple models have been employed to
calculate the biophysical parameters of the brain ISS. The basic model
is the unit cell model, which is suitable for describing diffusion
around cell bodies (Mathias, 1983; Rusakov and Kullmann, 1998).
Several advanced models consider the 2-D and 3-D geometry of the
ISS, such as the cubic model and the pore model (Deen, 1987; Chen
and Nicholson, 2000; Tao and Nicholson, 2004; Buxton et al., 2010).
Modeling of substance transport in the ISS is based on




¼ rðDrCÞ þ Q
a
f ðCÞv ! rC (1)
wherein C and Q represents the concentration and source of
concerned substance (e.g., the probe molecules) in ISF; r
represents gradient operator; f(C) represents the clearance rate
of the probe in ISS that depends on C and structures in the brain;
f(C) is especially important in studies of the microenvironment of
tumor, because its vascular system has clear exchange with ISSescriptions
olume fraction denotes the ratio of ISS volume to brain volume.
ortuosity denotes the length ratio of the actual movement path of a molecule to
traight distance in ISS.
ressure denotes the ISF stress
oundary area denotes the surface area of ISS boundary
riction denotes the ability of ISS boundary and ECM to resist the motion of ISF.
lasticity denotes the reversible extension ratio of the surface of ISS boundary
ermeability denotes the ability of substances to cross through ISS boundary.
iscosity denotes the ability of ISF to resist the relative motion between its
djacent layers.
olloid osmotic pressure is exerted by proteins and usually tends to pull water into
he solution. Crystal osmotic pressure is exerted by small molecules.
ensity denotes the mass of ISF in the unit volume
lectric conductivity denotes the ability of ISF to conduct an electric current.
hermal conductivity denotes the ability of ISF to conduct heat
oncentration denotes the amount of ions or molecules in unit volume of ISF.
low velocity denotes the movement speed of water; convective velocity is the
peed of ion or molecule movement caused by the bulk ﬂow of ISF.
iffusion rate denotes the movement speed of water, ions or molecules caused by
rownian motion.
he maximal distribution volume of tracer (i.e., Gd-DTPA) in brain tissue
he time duration that tracer amount decreases by a half
learance rate denotes the removal of tracer molecules in ISS.
tem: Anatomy, modeling, in vivo measurement, and applications.
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v ! represents the velocity of the bulk ﬂow of ISF; t represents
time; and D represents the diffusion tensor of concerned substance
having six independent elements only, i.e.,
Simplifying Eq. (1), the diffusion tensor D can be written as
(Nicholson, 2001):
D ¼ Dxxe ! xx þ Dyye ! yy þ Dzze ! zz (2)
where only the three diagonal elements of diffusion tensor are
considered if the axes of the coordinate system are chosen to be the
principal diffusion directions (PDDs) of the diffusion tensor.
For cases in which the diffusion is isotropic, the diffusion tensor
in above equation can be replaced by a scalar coefﬁcient (i.e., a
diffusion coefﬁcient). Moreover, when the bulk ﬂow and clearance









wherein D0 is the diffusion coefﬁcient of the probe in a free
medium, l represents the tortuosity, and r2 represents the
Laplace operator.
In solving the inverse problem of the above transport equations,
the desired biophysical parameters are calculated by a ﬁtting
process. Here we can have multiple solutions, because the
considered boundary condition is generally not sufﬁcient to select
a unique solution. In such cases, additional constraint conditions
can be considered, and here in these conditions are the pre-given
ranges of calculated parameters (such as tortuosity and volume
fraction). The ranges of key biophysical parameters in above
transport equations can be found in the above sections and
previous studies (Nicholson, 2001; Sykova and Nicholson, 2008). In
practical analyses, the scanned distribution of tracers or probes
(using MRI or optical imaging) has to be applied with an image
processing program to reduce the distortion (such as the offset of
scanned animals and the noise of images) that appeared during the
scanning process.
As mentioned above, many biophysical properties of the ISS and
associated parameters (in Table 2) may affect substance transport
in the ISS. Approximations of the spatial structure of ISS and ﬂuid
properties of ISF are considered when establishing above transport
equations. These approximations in modeling ISS boundaries and
ECM mostly include the following: (1) the ISS has a rigid spatial
geometry; (2) ISS boundaries has a smooth and uncharged surface,
and the inﬂuence of ECM is also ignorable. (3) ISS has an isotropic
structure. The following assumptions are common in modeling ISF:
(1) ISF is a continuous and uniform ﬂuid without suspended
component, and (2) the movement of the molecules in ISF is mainly
caused by diffusion.
Several works have shown efforts to incorporate the elasticity
of the ISS boundary into models (Raghavan and Brady, 2011; Haar
et al., 2014), although many parameters of ISS in Table 2 are
excluded. The above approximated models produce somewhat
consistent measurements, it is still important to include more
parameters from Table 2 into future biophysical modeling studies
of the ISS.
5. In vivo measurement techniques of brain ISS
In recent decades, numerous measurement techniques have been
developed for brain research. Most of these techniques are suitable
for investigating neural circuit, and a few general techniques can be
considered for measuring multiple brain compartments, such
as immunohistochemistry, microdialysis, electron microscopy,
and optical microscopy. Ex vivo immunohistochemical andPlease cite this article in press as: Lei, Y., et al., The brain interstitial sys
Prog. Neurobiol. (2016), http://dx.doi.org/10.1016/j.pneurobio.2015.immunoﬂuorescent stains have been particularly helpful for
analyzing the components of brain ECM, and microdialysis can
provide continuous monitoring of the local concentration of drugs
and metabolites of interest in the ISS.
Due to the ﬁxation and dehydration procedure involved in in
vitro measurements, the width and volume fraction of the ISS may
be under-estimated by traditional microscopy methods (Horst-
mann and Meves, 1959; Villegas and Fernandez, 1966; Coventry
et al., 1995; Chintala et al., 1996). Therefore, the biophysical and
biological properties of ISS-like small and dynamic structures
should be acquired and recorded in live brains or in live brain
slices. In this section, the current state-of-the-art techniques for in
vivo measurements of the ISS are introduced.
5.1. The principles of in vivo imaging and measurement of the
brain ISS
Three special techniques have been developed to measure or
image the brain ISS, including the ion-selected microelectrode
(ISM) (Nicholson and Rice, 1988; Nicholson, 2001), integrative
optical imaging (IOI) (Xiao et al., 2008), and tracer-based MRI
techniques (Benveniste and Blackband, 2002; Lee and Chang,
2004; Han et al., 2012; Han et al., 2014). ISM detects the electric
potential changes induced by the exogenous ions in the brain ISS
using an ion-selected microelectrode. Optical signals of ﬂuorescent
probes in the ISS is measured with IOI techniques. The tracer-based
MRI method is a novel measurement technique, and it uses
magnetic sensitive contrast agents as probes to label and trace
water molecules in ISF (Han et al., 2014). These measurements
share three basic procedures: (1) micropuncture to introduce or
inject probes into the ISS; (2) the detection and quantitative
measurment of the injected probe; and (3) post-processing and
calculation to extract the parameters.
Because no speciﬁc molecule is unique and suitable as a natural
endogenous probe for visualizing the brain ISS, exogenous probes
or tracers are employed in all measurement techniques. The probe
or tracer must satisfy the following requirements (Nicholson and
Tao, 1993; Han et al., 2014): (1) extracellular distribution: the
probe or tracer does not cross the capillary walls or the membranes
of neural cells, and thus is well constrained within the ISS; (2) good
biocompatibility: the probe or tracer is nontoxic to neurons and
does not cause gliosis; (3) biological or chemical inertness: the
probe or tracer does not react with the ECM or with substances
inside ISF; (4) diffusion properties: relatively small size, allowing
effective diffusion and distribution in the ISS; and (5) quantiﬁca-
tion: the concentration of the probe should have a clear monotonic
relationship with the intensity of detected signals (electric, optic,
and magnetic), which ensures the further calculation of diffusion
or ﬂow parameters in the ISS. The calculation of the biophysical
parameters of the ISS is based on both the selected diffusion model
and the obtained time proﬁle of probe concentration.
5.2. Ion-selected microelectrode techniques
The principle of ion-selected microelectrode (ISM) techniques is
usually known as voltammetry, i.e., a branch of electrochemistry.
In ISM techniques, the geometry of the brain ISS is quantitatively
measured with exogenous charged ions, and the current of the ions
is recorded by an ISM. The measured electric potential is converted
to the probe concentration for further calculations of ISS
parameters. According to their ability to drive the probe into
the ISS, ISM techniques are classiﬁed as real-time iontophoresis
(RTI) methods or real-time pressure injection (RTP) methods. The
selected charged ISM probes include TMA+, tetraethylammonium
(TEA), hexaﬂuoroarsenate (AsF6), and a-naphthalenesulfonate
(Nicholson et al., 1979; Nicholson and Philips, 1981).tem: Anatomy, modeling, in vivo measurement, and applications.
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they employs TMA+ as the probe. TMA+ is delivered from a special
micropipette into the brain sing the iontophoresis (Nicholson,
2001),the micropipette is a single barrel glass capillary containing
TMA+ with an inserted chloridized silver wire attached to a
constant current generator. That produces a positive current to
drive TMA+ into the ISS (Nicholson, 1992). The ISM is planted 20–
200 mm away and the local electrical potential is converted to the
concentration of the TMA+ ions (Hrabetova and Nicholson, 2007).
The measured concentration–time relation of TMA+ ions at a
known distance can then be used to extract the diffusion
parameters according to the classical diffusion equation (Sykova
and Nicholson, 2008). The small ion TMA+ (molecular weight of 74)
distributes mainly within the ISS and is not known to affect the
physiological functions of local tissues at the employed concen-
trations (Nicholson and Philips, 1981). As mentioned by Nicholson
(2001) and Kaur et al. (2008), TMA+ probe may enter neural cells
and the vascular system, which indicates that the TMA+ method
has a visible clearance term, i.e., f(C) in Eq. (1). RTI-TMA+ can
provide the diffusion coefﬁcient, volume fraction, tortuosity, and
clearance rate of probe within a distance of 10 to 200 mm
(Nicholson and Tao, 1993; Ujec et al., 1979).
In the RTP method, the tracer or probe is driven by pressure.
Commonly used probes include dopamine, ascorbic acid (Stamford
et al., 1985), and catecholamine (Leszczyszyn et al., 1990;
Wightman et al., 1991). However, the distribution volume of
these substances in RTP is not as easily controlled as in RTI
technique (Hrabetova and Nicholson, 2007; Rice et al., 2007).
5.3. Optical Imaging Techniques
In optical imaging techniques, ﬂuorescent molecules are
injected into the brain ISS and then detected with the aid of a
set of optical devices. Dextran, albumin, transferrin, and poly-
ethyleneglycol have been used as probes to visualize the brain ISS.
Unlike the probes used in ISM, the probes for optical imaging are
usually biologically active and may be captured by receptors,
which may decrease the accuracy of the measured ISS parameters.
Dextran is the most popular probe due to its high water solubility
and good biocompatibility. The employed size of dextran
molecules ranges from 3 kDa to 70 kDa (Nicholson and Tao,
1993; Xiao et al., 2008). The selected probe is injected into the
brain ISS of the cortex through a micropipette under external
pressure pulses, and the brain tissue with a probe in the brain ISS is
illuminated by excitation and bright-ﬁeld lights. The ﬂuorescent
probe molecules in the ISS are excited and transmit ﬂuorescence
light. The transmitted ﬂuorescence light passes through the
objective and dichroic mirrors, and is ﬁnally received and imaged
by a charge-coupled device (CCD) camera (Nicholson, 2001; Tao
and Nicholson, 1995; Hrabetova and Nicholson, 2007). The
received ﬂuorescence signal can be transformed to probe
concentration, the distribution process of probe molecules in
the brain ISS can be dynamically recorded, and the diffusion
coefﬁcient D and ISS tortuosity l can be calculated. To
quantitatively measure the parameters of the ISS, optical imaging
can be integrated with the RTI-TMA+ technique (Prokopova-
Kubinova et al., 2001).
Due to the detection limitations of light microscope, integrative
optical imaging (IOI) is mostly used to image the ISF ﬂow or
substances transport in the cortex, i.e., at a depth of approximately
200 (Tao and Nicholson, 1996; Thorne and Frey, 2001; Thorne
et al., 2008). The distribution of ﬂuorescence in 3D tissues can be
determined via laser scanning microscopy (LSM) (Thorne et al.,
2008; Xiao et al., 2008; Sherpa et al., 2014). Both single-photon and
multi-photon LSM techniques have been used. The multi-photon
technique takes advantage of longer wavelengths and is able toPlease cite this article in press as: Lei, Y., et al., The brain interstitial sys
Prog. Neurobiol. (2016), http://dx.doi.org/10.1016/j.pneurobio.2015.image deeper brain layers than the single-photon technique.
Moreover, simultaneous multi-ﬂuorescence channel imaging
enables the investigation of other structures in tissues, such as
the vascular system.
The RTI-LSM technique integrates the RTI and LSM techniques,
and is therefore able to image the distribution of optical probes in
the brain ISS, and to measure ISS volume fractions, diffusion
coefﬁcient, and ISS tortuosity (Xie et al., 2013). However, RTI-LSM
can only image superﬁcial brain tissue layers, the imaging depth is
within approximately 200 mm.
5.4. Tracer-based MRI and quantitative measurement
MRI has been widely used for in vivo imaging of biological
tissueS, because of its advantages of lminimal tissue damage,
excellent soft-tissue contrast, real-time monitoring, and global
imaging (Stejskal and Tanner, 1965; Le Bihan, 1995; Brooks and
Pavese, 2011; Ewers et al., 2011; Grodd and Beckmann, 2014).
Among the currently available brain ISS measurement techniques,
MRI is unique in detecting and imaging the brain ISS at the whole
brain scale, especially for investigations of the brain ISS in the deep
center of the brain (Han et al., 2014; Zuo et al., 2015; Shi et al.,
2015). The tracers used in MRI methods can be classiﬁed into
positive or negative groups, where positive tracers increase the
MRI signal intensity on T1 (longitudinal relaxation time) weighted
images and negative tracers decrease it on T2 (transverse
relaxation time) and T2* weighted images (Duong et al., 2001;
Han et al., 2012; Cabral et al., 2014; Han et al., 2014).
Negative tracers, e.g., super paramagnetic iron oxide (SPIO),
have been successfully used to investigate the drainage route of the
traced brain ISF, although the signiﬁcant susceptibility to artifacts
and distortion of the brain parenchyma make it impossible to
image and quantitatively measure brain ISS parameters (Muldoon
et al., 2005; Muthana et al., 2015). Gd-DTPA is a positive contrast
agent frequently used in clinical applications. Compared with
other ion or ﬂuorescent probes, Gd-DTPA has many advantages,
including biological inertness, thermal stability, small molecular
size, and extracellular distribution (Caravan et al., 1999; Han et al.,
2014). At the employed concentration, Gd-DTPA does not cause
any distortion or artifacts of the brain parenchyma on MRI.
Furthermore, Gd-DTPA can trace endogenous water molecules in
brain ISF by shortening the spin-lattice relaxation time of hydrogen
nuclei in water molecules within an effective distance of 2.5 A˚,
which is visible as a high signal on MR images (Han et al., 2012).
Gd-DTPA has been used in previous studies to simulate or trace the
substances transport in the brain ISS (Shoesmith et al., 2000), while
the calculation of brain ISS parameters was not available until a
study conducted by Xu and Han in 2011b: a special 3-D T1-
weighted imaging sequence was developed and modiﬁed to
quantitatively measure the concentration of Gd-DTPA in real time
(Xu et al., 2011b).
The tracer-based MRI enables a ‘‘one-stop shopping’’ acquisition
of many transport and distribution parameters in brain ISS,
including Vdmax, t1/2, D, l (Han et al., 2014). After the injection of
tracer into the brain ISS, the tracer is diluted and the signal intensity
in MRI decreases gradually, which presents as an attenuation of the
signal enhancement on a series of MR images (Han et al., 2012). In
the inverse problem of transport equations, the extracted diffusion
parameters depend on the measured concentration of the injected
probe in the brain ISS over time domain. In this tracer-based MRI
measurement of the brain ISS, an image processing program must be
applied before the ﬁtting process of parameter extraction, and it is
designed to eliminate the distortions of scanned MRI data and to
calculate the Gd-DTPA concentration (Xu et al., 2011b; Li et al.,
2013). The major functions of this image processing program include
the removal of MRI noise, the rigid registration for scanned images,tem: Anatomy, modeling, in vivo measurement, and applications.
12.007
Fig. 5. Procedure for measuring the ISS within the rat brain using the tracer-based MRI technique (above) and the ‘‘lightened’’ water molecules by MRI tracer Gd-DTPA (below
left). Step A: MRI pre-scanning is applied to the rat to acquire the pre-contrast image; Step B: intraparenchymal microinjection of Gd-DTPA into the rat brain to enhance the
MRI signal intensity of the water molecules within the ISS; Step C: the concentration distribution of MRI tracer can be obtained by subtracting the pre-contrast image from
post-processing images; Step D: analysis of the distribution of MRI tracers and calculation of ISS parameters. The scanned MR images of the rat show that the brain is a
physiologically partitioned system referring to the distribution of MRI tracers in the brain ISS (below right).
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injected Gd-DTPA probe.
As shown in Fig. 5, using the tracer-based MRI technique, the
ﬂow (or transport) of the traced brain ISF from the deep center of
the rat brain can be investigated, The results indicate that the brain
ISS is a physiologically partitioned system, and each division is
characterized by the unique distribution territory and drainage
velocity of the traced brain ISF. The location-dependent properties
of the ISF drainage system will improve our understanding of the
ISS, and provide a useful reference for optimizing the technique for
local brain drug delivery (Guerin et al., 2004; Gulati et al., 2012).
Thus far, the tracer-based MRI technique is the only measurement
technique that provides a global view of 3-D visualization of the
dynamic drainage ﬂow of brain ISF. Moreover, this technique can
also produce multi-point measurements of diffusion parameters
along any direction near the injection site. Additionally, giving
potential independence and ‘‘lighting’’ endogenous water mole-
cules, this tracer-based MRI technique may provide a special
advantage in analyzing and predicting the dynamic distribution of
water-soluble drugs in the brain (Xu et al., 2011a).
It is challenging to develop a non-invasive measuring
technique, that provides both the diffusion parameters of water
molecules in the brain ISS and the anisotropic structure of various
compartments in brain tissue (Le Bihan et al., 1988). To establish
such a technique, four questions must be satisfactorily answered.
The ﬁrst question is how to model the anisotropic movement
(including diffusion and bulk ﬂow) of water molecules. The
second is how to include all the major compartments (i.e., vessels,
ISS and neural cells) of brain tissue in the mathematical model of
MRI signal intensity. The third one is that how to distinguish the
various compartments according to the movement characteristics
of water molecules. The last is how to efﬁciently calculate the non-
convex inverse problem of desired modeling while considering
the anisotropic movement of water molecules as multiple
compartments.
5.5. Microdialysis technique
Microdialysis sampling was ﬁrst established in 1966 (Bito et al.,
1966), and it is the only sampling technique that can continuously
monitor drugs and metabolite concentrations in the brain ISS. This
real-time analysis method barely disturbs the local BME because
there is no ﬂuid loss or pressure artifact (Portas et al., 2000;
Herrera-Marschitz et al., 2010).
The sampling system consists of a microdialysis pump, micro-
dialysis probe, and microvial. With the aid of a stereotactic
positioning coordinate system, the microdialysis probe is plantedPlease cite this article in press as: Lei, Y., et al., The brain interstitial sys
Prog. Neurobiol. (2016), http://dx.doi.org/10.1016/j.pneurobio.2015.into the target location in the brain tissue. Driven by the pump, the
perfusate (mainly Ringer’s solution or artiﬁcial CSF) enters the
microdialysis probe at a velocity of 0.5–5 ml per minute. The
semipermeable membrane in the tip, which has a diameter of 0.15–
0.3 mm, is the most important unit of the microdialysis system
(Benjamin et al., 2004). The perfusate is driven though the probe and
collected in a microvial, where the collected liquid is called the
dialysate (Plock and Kloft, 2005). Different types of semipermeable
membranes have been designed for different purposes and tissues,
and each type of semipermeable membrane can be distinguished fby
its speciﬁc molecular weight cut-off, shape, and material (Hoistad
et al., 2002). The exchangeable substances usually range from 6 kDa
to 100 kDa, large molecules and proteins cannot diffuse through the
membrane (Chefer et al., 2009).
The quantiﬁcation of sampled molecules in dialysates from
brain ISF is conducted with general analysis devices, such as high-
performance liquid chromatography (Kanno et al., 2004), liquid
chromatography mass spectrometry (Larmene-Beld et al., 2014),
nuclear magnetic resonance (Khandelwal et al., 2004), radiotracer
(Bernards et al., 2003), liquid scintillation spectrometry (Hoistad
et al., 2002), gas chromatographic analysis (Winter et al., 2004),
and ﬂame ionization (Lindberger et al., 2001).
6. ISS and brain disorders
In this section, we describe neuropathologic alterations in the
ISS caused by several common brain disorders. Neuropathologic
alterations of the ISS can generally be classiﬁed as follows: (1) ISS
geometry, i.e., changes in volume fraction and tortuosity (Hrabe-
tova et al., 2009); (2) ECM and its components (Bekku et al., 2010);
(3) the components and biochemical properties of ISF; and (4)
substance transport and ISF ﬂow in the ISS (Lehmenkuhler et al.,
1991; Lehmenkuhler et al., 1993; Kohling and Lehmenkkhler,
1993; Schwindt et al., 1997; Chen et al., 2005). The purpose of the
above classiﬁcation is to facilitate the depiction and quantitative
studies of the ISS, although different alterations may occur
together or follow each other (Zoli and Agnati, 1996).
6.1. Glioma
Uncontrolled growth of tumor cells in glioma can destroy the
normal architecture of brain tissue, and this pathological damage is
accompanied by the biochemical processes of proteolytic degra-
dation of ECM and active movement of tumor cells (Birlik et al.,
2006).
Alterations of ISS geometry have a clear relationship with the
invasiveness and malignancy of glioma. Compared to normal braintem: Anatomy, modeling, in vivo measurement, and applications.
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may be increased in low-grade diffuse astrocytomas, anaplastic
astrocytomas, and a further increase is demonstrated in solid
portions of high-grade astrocytomas (Vargova et al., 2003). In
pilocytic astroglioma and ependymoma, a is increased without any
change in l. No change in the ISS geometry is found in
oligodendroglioma (Zamecnik et al., 2004). Increased a of ISS
has been veriﬁed in tenascin-accumulated astrocytoma but not in
tenascin-negative tumors (Mahesparan et al., 2003). In high-grade
glioma, the overproduction of tenascin familial aggregation of ECM
may be the cause of increased l and restricted diffusion (Zamecnik,
2005). Components of the ECM such as laminin, collagen IV,
tenascin and hyaluronic acid have been shown to be preferred
substrates for glioma spread and are ECM components in the
pathways of known dissemination (Goldbrunner et al., 1998).
Glioma EVs in brain ISF carry a variety of biomolecules such as
oncogenic growth factors, receptors, enzymes, transcription
factors, and signaling and immunomodulatory molecules. These
EVs can support malignancy of glioma, including tumor
growth, expansion, invasion, and survival against host immune
responses.
Substance transport in the ISS is signiﬁcantly restricted in ISS of
glioma, as indicated by the increased tortuosity (Li et al., 2013; Han
et al., 2014). Moreover, the interstitial ﬂuid pressure (IFP) increases
with tumor volume in glioma, which reduces the driving force
behind the convective transport of substances and drugs across
capillary. To improve transport in the ISS, especially large
molecular transport, convection enhanced delivery (CED) has
been investigated to improve the drug distribution in brain tumors.
In CED, one or more catheters is stereotactically placed directly
into brain tumors or tissues through cranial burr holes.
Therapeutic agents are continuously administered through the
catheter with a positive pressure gradient at the catheter tip. As the
pressure is maintained, it creates convection to supplement the
diffusion of drugs through ECS, thus enhancing the distribution of
the drug to the targeted area. In 2010, a phase III clinical trial of
anti-tumor agentsadministrated via brain ECS was approved by the
United States Food and Drug Administration. (Kunwar et al., 2010).
More details about CED are presented in Section 7.
6.2. Ischemic stroke
Ischemic stroke is commonly deﬁned as a sudden loss of
neurological function resulting from insufﬁcient cerebral blood
ﬂow. The low blood supply leads to the delivery of both oxygen and
energy substrates at levels below metabolic requirements. In the
very early stages of ischemic stroke, excessive water is transported
into neural cells, especially astrocytes, due to disorders of Na+-K+
pumps resulting from energy failure and blood–brain barrier
disruption, and cytotoxic edema presents as marked swelling of
the cell bodies and processes. (Steiner et al., 2012).
These pathological changes dramatically decrease the ISS
volume and increase the ISS tortuosity. The ISS a decreases
obviously from 0.20 to 0.05, and l increases from 1.5 to 2.1 (Sykova
et al., 1994; Vorisek and Sykova, 1997). The increase in l during
ischemia is accompanied by a reduction in diffusion, and this is
suggested to be caused by dead-space in the micro domains of ISS
(Hrabetova et al., 2003).
Alterations of ISS geometry block the ISF drainage route (Arbel-
Ornath et al., 2013), which results in the accumulation of
numerous harmful factors released from the damaged neural cells
(such as glutamate, pro-apoptotic factors, pro-inﬂammatory
factors and free radicals). This accumulation further aggregate
the damage.
Additionally, the constituents of ISF are remarkably changed
following an ischemic attack. Increase in lactate and glutamate andPlease cite this article in press as: Lei, Y., et al., The brain interstitial sys
Prog. Neurobiol. (2016), http://dx.doi.org/10.1016/j.pneurobio.2015.decrease in glucose in ISF can be detected by microdialysis
measurements. Osteopontin accumulates in the ECM 5–15 days
after stroke, and ﬁnally forms the boundary of the glial scar
(Hobohm et al., 2005; Al’Qteishat et al., 2006). The elimination of
brain edema (both vasogenic and cytotoxic edema) and reestablish
the ISF clearance route may provide new avenues to alleviate
pathological processes under ischemic injury. Moreover, the
efﬁciency of administration of neuronal protective agents to treat
brain ischemic damage via brain ISS has been recently veriﬁed
using cytidinediphosphate choline (CDPC) (Xu et al., 2011b).
6.3. Alzheimer’s disease
Alzheimer’s disease (AD) is characterized by the loss of neurons
in the cortex, where neuroﬁbrillary tangles accumulate inside
neurons and amyloid beta (Ab) deposits accumulate in the brain
ISS (Mudher and Lovestone, 2002; Nistor et al., 2007; Burns and
Iliffe, 2009). The above pathological changes caused increased a
and l in the cortex in a mouse AD model (Sykova et al., 2005).
Ab is a fragment of the transmembrane amyloid precursor
protein (APP). In AD,the enzyme degrades APP to smaller
fragments in the brain ISS(Hooper, 2005). These fragments give
rise to ﬁbrils of Ab, which forms clumps that are deposited outside
neurons in dense formations known as senile plaques (Ohnishi and
Takano, 2004). Some components of ECM contribute to the
formation and stabilization of Ab plaques in the brain ISS, such
as HSPGs, perlecan, agrin, collagen XVIII and syndecans and
glypicans, and these can form complexes with both the dense and
diffuse types of Ab plaque (Snow et al., 1990; Verbeek et al., 1999;
Cotman et al., 2000; van Horssen et al., 2002; Miosge et al., 2003;
van Horssen et al., 2006). A signiﬁcant reduction in reelin-
expression is found in AD brains (Fatemi, 2005). There is evidence
that reelin negatively affects Ab accumulation when it interacts
with apolipoprotein E (APOE) receptor 2 and low density
lipoprotein (LDL) receptor 2 (Hoe et al., 2006). Although Ab has
been associated with the brain ECM, how and why Ab accumulates
in the cerebral cortex is unclear; this issue needs to be further
explored and clariﬁed.
The drainage of brain ISF is crucial for the clearance of Ab.
Soluble Ab in ISF reaches the capillar bedsy beds, and the basement
membranes between smooth muscle cells in the tunica media of
arteries (Weller et al., 1998, 2009a, 2009b). Blockage of brain ISF
drainage accelerates the abnormal deposition of Ab and is closely
associated with neuronal degeneration (Iliff et al., 2012; Arbel-
Ornath et al., 2013). In addition to the above drainage within ISF,
Ab drains through the perivascular space to reach the CSF, and the
concentration of Ab in CSF is signiﬁcantly altered in dementia
(Blennow et al., 2010).
The ISF-CSF communication pathway in the subarachnoid space
has been applied to develop an alternative CNS drug delivery
strategy, i.e., intranasal administration. Here drugs delivered
intranasally are transported along olfactory sensory neurons to
yield signiﬁcant concentrations in the CSF and olfactory bulb
(Misra et al., 2003). Using this method, the therapeutic neurotropic
factor is delivered to the olfactory bulb to treat AD. Proposed
pathways of ISF drainage are illustrated in Fig. 2. An in-depth
understanding of the ISS may facilitate the discovery of new ways
to reduce Ab accumulation and damage in CNS disorders.
In addition to the above common brain diseases, alternations of
the ISS have also been reported in other diseases, such as
Parkinson’s disease (Marti et al., 2010), multiple sclerosis
(Simonova et al., 1996; van Horssen et al., 2007; Sykova and
Nicholson, 2008; Miabi et al., 2010), and epilepsy (Rogawski,
2009). With progress in the in vivo techniques of ISS measurement,
the links between ISS properties and brain disorders will be further
clariﬁed at cellular or sub-cellular levels.tem: Anatomy, modeling, in vivo measurement, and applications.
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7.1. The demand for drug delivery via ISS
Brain disorders, such as brain tumors, AD, and stroke, are a
signiﬁcant cause of human disability, and the patients suffering
from brain disorders are far more than the people dying of all types
of systemic cancer and cardiovascular diseases. Due to the risks
and side effects of surgical treatment, pharmacotherapy is the
preferred approach for treating brain disorders. However, due to
the use of standard drug delivery by intravenous infusions, the
clinical success rate of new CNS drugs is only 7%, compared with
approximately 15% for other types of drugs (Pangalos et al., 2007;
Wolak and Thorne, 2013). Standard trials of drug delivery to the
brain by intravenous infusions have revealed limited penetration
of the brain tissue, and the clinical failures of many potentially
effective therapeutics for brain disorders is due to our inability to
effectively deliver and sustain drugs within the brain (Modi et al.,
2009). This inability is partly due to the lack of knowledge of the
BME.
The investigation of neuro-protective drugs for ischemic stroke
is an example of the dilemma of standard drug delivery, which has
taken several decades, cost billions of dollars, and led to complete
failure in clinical applications. The vascular compartment takes up
only 3% to 5% of the total brain volume and the administered drug,
but all the previous drug investigations and clinical trials in this
ﬁeld have considered the vascular compartment the preferred
route of administration to the ischemic or penumbra region of the
brain. (Fisher et al., 2009; Bidros et al., 2010). (Macdonald et al.,
2008; Lees et al., 2013). With traditional oral or intravenous
administration, the drug needs to reach the ischemic region where
there has been no blood supply or low perfusion for a substantial
period. Additionally, the BBB allows only very low penetration, and
the cerebral microvasculature in tumor adjacent regions of
normal brain may be even less permeable to drugs (Misra et al.,
2003). Finally, if the drug can pass the BBB, it still must travel
from the capillary bed to the cells under ischemic injury (Fuxe
et al., 2010).
In response to this dilemma of standard drug delivery,
aggressive efforts have focused on the development of new
strategies to more effectively deliver drugs, such as BBB disruption,
Liposomes and nanoparticle soluble drugs (Figley and Stroman,
2011). These methods focus on how the drug molecules pass
through the BBB. Becasue the ISS provides a direct space for
substance transport and exchange among neural cells, local drug
delivery via ISS attracts the attentions of scientists. Local brain
drug delivery via the ISS is a highly technical procedure that
involves the stereotactic placement of a catheter through cranial
burr holes directly into the brain tissue or target (e.g., tumor).
Therapeutic agents are administered through the catheter, and
using a micro-infusion delivery system, a concentration gradient is
created at the catheter tip driven by pressure. The procedure
creates enhanced ﬂow of the drugs through the extracellular
spaces and the drug distribution to the targeted area. The aim of
local drug delivery is to distribute the drug at higher concentra-
tions to brain lesions. Based on the driven force and mechanism of
the drug’s transport in the ECS, local drug delivery can be classiﬁed
as convection enhanced delivery (CED) simple diffusion delivery
(SDD).
Although local delivery via the ISS is still an experimental
method due to regarding its safety and efﬁcacy, this novel method
shows advantages compared to the dilemma of standard drug
delivery, including bypass of the BBB, targeted distribution
through large brain volumes, and limited systemic side effects.
As an example, the practical application of neuro-protective drug,
CDPC for ischemic stroke has been difﬁcult in previous researchPlease cite this article in press as: Lei, Y., et al., The brain interstitial sys
Prog. Neurobiol. (2016), http://dx.doi.org/10.1016/j.pneurobio.2015.(Clark and Clark, 2012). Recently, the administration of a very
small dose CDPC through the brain ISS using a novel SDD method
has proven more efﬁcient than standard trials (Han et al., 2011; Xu
et al., 2011a).
According to the illustrations presented in Section 4, we know
that many factors affect the transport of therapeutic drug agents in
the brain ISS, such as electric charges and pressure, and controlling
the distribution or transport speed of injected drugs in the brain ISS
is particular complex. In the future, several goals would be
attractive for scientists in the area of local drug delivery via the ISS:
(1) modeling of substance transport in the ISS and prediction of the
dynamic distribution of CNS drugs, and (2) the development of
high-efﬁciency and safe methods of regulating the transport of
drugs or substances in the brain ISS (Shi et al., 2015).
7.2. Convection enhanced delivery
Although the ﬂow and transport of ISF in the ISS at the whole-
brain scale were far from clear in the early 1990s, scientists had
begun to investigate the possibility of using the ISS to delivery
drugs to circumvent the BBB. ISS-based drug delivery is also known
as CED in the literature, which is conducted with the continuous
injection of the therapeutic agent under positive pressure via a
catheter implanted into the brain (Bobo et al., 1994; Debinski and
Tatter, 2009; Barua et al., 2013; Anderson et al., 2013; Barua et al.,
2014). Based on a retrospective clinical study, it was reported that
infusion parameters may improve the efﬁciency of drugs delivered
by CED (Sampson et al., 2010).
CED offers a number of advantages over conventional drug
delivery methods, including bypass of the BBB, minor systemic
toxicity and better efﬁcacy. Despite showing great promise in the
treatment of high-grade glioma, PD and AD, substantial
reﬁnements are necessary before CED can be successfully
translated to the clinic, primarily in the following areas: (1) the
back ﬂow of injection in CED may degrade its performance; (2) the
concentration and distribution of the injected drug cannot be
easily predicted and controlled (Sampson et al., 2009; Barua et al.,
2012a, 2012b); (3) the side effects of CED may be signiﬁcant in
practical applications due to mechanical damage to brain tissue
(Lidar et al., 2004; Slevin et al., 2006; Bruce et al., 2011). Because of
the above technical challenges, great efforts are still dedicated to
optimizing CED technology, e.g., implantable intermittent delivery
(Barua et al., 2013).
All of the above problems originate from an incomplete
understanding of the ISS in the normal brain and tumors,
inevitable changes in ISS structures caused by drug infusion,
and the pharmacokinetics of CED are still poorly understood
(Sampson et al., 2009). Local brain drug delivery would be more
practical, if the distribution and the processes of brain ISF in the
live brain could be monitored and quantitatively analyzed, An
effective method is therefore needed to optimize the operational
parameters, including infusion rate, catheter design, catheter
placement and a feasible pharmacological formulation.
7.3. Simple diffusion delivery
Simple diffusion delivery (SDD) is a recently developed local
brain drug delivery method that uses the concentration gradients
to drive pharmaceutical agents to target zones via the brain ISS
(Han et al., 2011). It was previously believed that the brain ISS
was highly connected, such the molecules could travel through
multiple pathways to reach another location at any given point in
the brain ECS. However, according to new results based on the
tracer-based MRI technique, no such global distribution has been
demonstrated. Instead, a new ISS division system based on brain
ISF ﬂow distribution territories has been revealed and has beentem: Anatomy, modeling, in vivo measurement, and applications.
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Nicholson, 2008). (Han et al., 2011; Han et al., 2014; Li et al.,
2015). SDD is based on the above ﬁndings of the brain ISS
divisions and the properties of substance transport in each
division. Before or during SDD, the tracer-based MRI technique
has been used to trace the dynamic distribution of the water
soluble probe Gd-DTPA, along with the transport and ﬂow of
water molecules in the brain ISF. Due to the inertness of Gd-
DTPA, its biophysical parameters provide the net background or
reference for other water soluble agents, such as CDPC.
Therefore, compared to CED, the unique advantage of SDD is
that the dynamic distribution of drugs in any speciﬁc division
can be simulated and the full immersion and contact with target
cells makes treatment with only small doses of drug more
effective (Xu et al., 2011b). Moreover, the delivery process
without continuous pressure avoids the drawbacks of the CED
method, e.g., unwanted backﬂow, uncontrollable distribution,
and tissue damage.
Both CED and SDD are promising methods for local drug
delivery to the brain, although several challenges remain to be
overcome before their practical application in clinical treatment.
Of particular importance is to clarify the inﬂuence of factors (e.g.,
injection pressure) on the distribution and spread rate of drugs in
various brain ISS divisions. Another important issue is the manual
method for regulating the distribution and transport of drugs in
each brain division (Shi et al., 2015). We have successfully applied
prophylactic treatment for ischemic stroke in rats by injecting
CDPC based on the SDD method. The effective dose via the brain ISS
was only approximately 0.1% of that applied through the vascular
system (Xu et al., 2011a).
8. Conclusion
The brain is a delicate organ that has evolved over millions of
years, and it provides an efﬁcient means for humans to feel and
respond to the outside environment, and have intelligence and
consciousness. Brain functions can be inﬂuenced by the dynamic
internal environment (especially the ISS), which is an important
aspect of neuroscience research. With the consideration of the
ISS, new perspectives on brain research will expand our
understanding of basic brain functions and mechanisms, such
as perception, reﬂection, motion, cognition, memory, and
emotion.
The ISS is an elastic porous structure that supports the brain
organization, and the contents of the tortuous and narrow ISS,
including solutes and ECM, maintain a dynamic balance to
support the viability of neural cells. Due to the complexity of
this system, however, many mechanisms and properties of the
ISS remain unknown. To understand these issues, we need to
develop new techniques to study the brain ISS, including
biophysical modeling, next generation brain imaging
techniques, and techniques for large-scale recording and signal
modulation in the CNS, which were not discussed in this
review. The results from ISS research can be used to improve
the treatment of brain disorders through the development of
new drugs or novel delivery systems for drugs, genes and stem
cells.
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